Surmodics to Host Virtual Annual Meeting of Shareholders
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Feb 5, 2019--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, will hold its Annual Meeting of Shareholders on Wednesday, February 13, at 4 p.m. CT (5:00 p.m. ET), as a virtual meeting.
Gary Maharaj, chief executive officer, and Sue Knight, chair of the board, will provide a brief update on business and key strategic initiatives underway at the Company.
To attend the virtual meeting, go to www.virtualshareholdermeeting.com/SRDX19 at least five minutes prior to the start of the meeting to log in. A webcast replay of the Annual Meeting will be available until February 13, 2020.
About Surmodics, Inc.
Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays. Surmodics is pursuing highly differentiated whole-product solutions that are designed to address unmet clinical needs for its medical device customers and engineered to the most demanding requirements. This key growth strategy leverages the combination of the Company’s expertise in proprietary surface technologies, along with enhanced device design, development and manufacturing capabilities. The Company mission remains to improve the detection and treatment of disease. Surmodics is headquartered in Eden Prairie, Minnesota. For more information, visit www.surmodics.com. The content of Surmodics’ website is not part of this press release or part of any filings that the company makes with the SEC.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190205005285/en/
CONTACT: Tim Arens
KEYWORD: UNITED STATES NORTH AMERICA MINNESOTA
INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES MEDICAL SUPPLIES
SOURCE: Surmodics, Inc.
Copyright Business Wire 2019.
PUB: 02/05/2019 08:30 AM/DISC: 02/05/2019 08:30 AM